ATS 2019 Virtual Final Program

to care all contribute to the negative impact of rural residence on COPD. The interaction of rurality and COPD is of growing interest, but key gaps in knowledge exist. This session will explore the rural COPD disparity by expanding the learners understanding of aspects of rural COPD research as well as novel clinical interventions that improve the care of rural COPD patients. Chairing: M.C. McCormack, MHS, MD, Baltimore, MD A. Lambert, MD, MHS, Spokane, WA R.M. Burkes, MD, Chapel Hill, NC 9:15 Welcome and Introduction M.C. McCormack, MHS, MD, Baltimore, MD 9:20 Rural Disparities in COPD: Where Are We Now? J. Croft, PhD, Atlanta, GA 9:40 The Relationship Between COPD Risk and Rural Exposures L.M. Paulin, MD, Lebanon, NH 10:00 The Role of Health Care Access in Rural COPD M.B. Drummond, MHS, MD, ATSF, Chapel Hill, NC 10:20 Community Paramedicine as a Novel Care Delivery Model M. Merrell, PhD, Columbia, SC 10:40 Delivering Pulmonary Rehabilitation to Rural Communities D. Doyle, MD, Dawes, WV 11:00 Question and Answer Discussion M.C. McCormack, MHS, MD, Baltimore, MD BEHAVIORAL • CLINICAL • TRANSLATIONAL CRITICAL CARE TRACK CME Credits Available: 2 D4 BIG DATA AND CLINICAL TRIALS: FRIENDS, FOES, OR FRENEMIES? Assemblies on Critical Care; Behavioral Science and Health Services Research; Nursing; Pediatrics 9:15 a.m. - 11:15 a.m. OMNI DALLAS DOWNTOWN Dallas Ballroom D/H (Level 3) Target Audience All healthcare workers caring for critically ill patients. The topics are targeted towards a multidisciplinary audience Objectives At the conclusion of this session, the participant will be able to: • provide an update to attendees about latest innovations in big data analytics; • enable clinicians to objectively assess research scenario where big data methods can be applied to answer research questions and situations where their application may not be ideal; • provide healthcare workers with insights into how to perform bigger and smarter clinical trails. Additionally, there will be working illustrations of how to maximize electronic health records for research puropses. Critical care is one of the most challenging environments to conduct clinical trials. Consequently, many trials have resulted in negative results or failed to adequately answer important research questions. In this symposium, we ask whether emerging methods in “Big Data” can be leveraged to address some of the challenges facing critical care researchers. We explore how Big Data methodologies can be incorporated into trial design to facilitate efficient, timely, and effective patient recruitment. We will explore whether current methods that use traditional structured clinical data to silo patients for trials is a hindrance and how we extract more information from the data that we collect from ICU patients. Chairing: M.M. Churpek, MD, MPH, PhD, ATSF, Chicago, IL P. Sinha, BSc(Hons), MBBCh, PhD, San Francisco, CA M.N. Gong, MS, MD, Bronx, NY 9:15 Big Data: The Real Deal or the Emperor’s New Clothes? M.M. Churpek, MD, MPH, PhD, ATSF, Chicago, IL 9:30 Using Big Data When Clinical Trials Are Unethical or Challenging: The Case of Sepsis V. Liu, MD, MS, Oakland, CA 9:45 We Still Need Clinical Trials: An Epidemiologist’s Perspective T.J. Iwashyna, MD, PhD, Ann Arbor, MI 10:00 Are “Bigger Trials” the Answer? The ANZICS Experience P. Young, MBChB, BSc (Hons), PhD, Wellington, New Zealand 10:15 “Smarter” Not Just “Bigger” Data: Lessons from Oncology in Adaptive Trial Design and Applications to Critical Care C.S. Calfee, MD, San Francisco, CA 10:30 Clinical Trials of the Future: Utilizing EHR to Facilitate RCTs of Critical Care Fluid Management M.W. Semler, MD, MSc, Nashville, TN 10:45 Using Big Data for Early Identification of Syndromes for Clinical Trial Enrollment M.N. Gong, MS, MD, Bronx, NY 11:00 ARDS: From Subphenotype Discovery to Enriched Clinical Trials P. Sinha, BSc(Hons), MBBCh, PhD, San Francisco, CA BEHAVIORAL • CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM CME Credits Available: 2 MOC Points Available: 2 D5 SLEEPING WITH THE ENEMY: EXPLORING THE IMPACT OF SLEEP DISORDERED BREATHING ON CANCER Assemblies on Sleep and Respiratory Neurobiology; Thoracic Oncology 9:15 a.m. - 11:15 a.m. KBHCCD Room D163/D165/D170/D172 (Level 1) Target Audience Respiratory, primary care and internal medicine specialists, nurses, sleep technicians and investigators who are interested in sleep apnea and/or cancer research, diagnosis and management Objectives At the conclusion of this session, the participant will be able to: • improve critical analysis of the available basic, translational and clinical information regarding the association of OSA with different types of cancer; • gain new findings about epidemiological and clinical studies and the potential mechanisms involved in the association with OSA and cancer. ATS 2019 • Dallas, TX 314 WEDNESDAY • MAY 22